Funding to advance Canada's countermeasures in the fight against COVID-19

From: Innovation, Science and Economic Development Canada

Thank you for the high level of interest regarding funding available under the Strategic Innovation Fund for supporting COVID-19 related vaccines and therapies clinical trials. This initiative was closed on May 11, 2020 for the current round of funding

Firms seeking support for bio-manufacturing opportunities can continue to apply as detailed below. You can still communicate with the SIF Integration Team at the following address: ic.sifintegrationteam-equipeintegration-fsi.ic@canada.ca for inquiries. Thank you for your interest.

Further to the Government's announcement on April 23, 2020, the Strategic Innovation Fund will support projects to advance Canada's medical countermeasures in the fight against COVID-19. This includes support for COVID-19 related vaccine and therapy clinical trials led by the private sector, and Canadian bio-manufacturing opportunities.

Vaccines and Therapies

This initiative was closed on May 11, 2020 for the current round of funding.

Bio-manufacturing

If you are an entity incorporated in Canada that has a project that expands domestic bio-manufacturing capacity related to COVID-19, please complete the standard Statement of Interest (SOI) form. The SOI (Streams 1–3) is available on the SIF web site under Helpful Links / Program Guide and Application Toolkit.

April 23, 2020 Announcement.

Date modified: